These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15700967)

  • 1. Paralog-selective ligands for bcl-2 proteins.
    Gemperli AC; Rutledge SE; Maranda A; Schepartz A
    J Am Chem Soc; 2005 Feb; 127(6):1596-7. PubMed ID: 15700967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
    Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
    Kneissl S; Loveridge EJ; Williams C; Crump MP; Allemann RK
    Chembiochem; 2008 Dec; 9(18):3046-54. PubMed ID: 19012295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.
    Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A
    Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition.
    Sadowsky JD; Schmitt MA; Lee HS; Umezawa N; Wang S; Tomita Y; Gellman SH
    J Am Chem Soc; 2005 Aug; 127(34):11966-8. PubMed ID: 16117535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The solution structure of pGolemi, a high affinity Mena EVH1 binding miniature protein, suggests explanations for paralog-specific binding to Ena/VASP homology (EVH) 1 domains.
    Link NM; Hunke C; Mueller JW; Eichler J; Bayer P
    Biol Chem; 2009; 390(5-6):417-26. PubMed ID: 19284291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
    Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
    Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms.
    Qian J; Voorbach MJ; Huth JR; Coen ML; Zhang H; Ng SC; Comess KM; Petros AM; Rosenberg SH; Warrior U; Burns DJ
    Anal Biochem; 2004 May; 328(2):131-8. PubMed ID: 15113688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TR3/Nur77 peptide-based high-throughput fluorescence polarization screen for small molecule Bcl-B inhibitors.
    Yip KW; Godoi PH; Zhai D; Garcia X; Cellitti JF; Cuddy M; Gerlic M; Chen Y; Satterthwait A; Vasile S; Sergienko E; Reed JC
    J Biomol Screen; 2008 Aug; 13(7):665-73. PubMed ID: 18626112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
    Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of backbone space in foldamers containing alpha- and beta-amino acid residues: developing protease-resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-xL.
    Sadowsky JD; Murray JK; Tomita Y; Gellman SH
    Chembiochem; 2007 May; 8(8):903-16. PubMed ID: 17503422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM; Tian D; Xing C
    J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage display screen for peptides that bind Bcl-2 protein.
    Park HY; Kim J; Cho JH; Moon JY; Lee SJ; Yoon MY
    J Biomol Screen; 2011 Jan; 16(1):82-9. PubMed ID: 21131596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
    Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
    J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein.
    Rodi DJ; Janes RW; Sanganee HJ; Holton RA; Wallace BA; Makowski L
    J Mol Biol; 1999 Jan; 285(1):197-203. PubMed ID: 9878399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
    Yin H; Hamilton AD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of structure--activity relationships among foldamer ligands for a specific protein binding site via parallel and split-and-mix library synthesis.
    Murray JK; Sadowsky JD; Scalf M; Smith LM; Tomita Y; Gellman SH
    J Comb Chem; 2008; 10(2):204-15. PubMed ID: 18275161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.